Intersect ENT
XENT
#5209
Rank
$0.95 B
Marketcap
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)

P/E ratio for Intersect ENT (XENT)

P/E ratio at the end of 2020: -10.2

According to Intersect ENT's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -12.7207. At the end of 2020 the company had a P/E ratio of -10.2.

P/E ratio history for Intersect ENT from 2014 to 2020

PE ratio at the end of each year

Year P/E ratio Change
2020-10.2-43.72%
2019-18.2-48.21%
2018-35.1-39.35%
2017-57.9325.56%
2016-13.6-37.67%
2015-21.883.49%
2014-11.9

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-7.84-38.33%๐Ÿ‡บ๐Ÿ‡ธ USA
53.6-521.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-16.6 30.51%๐Ÿ‡บ๐Ÿ‡ธ USA
33.7-364.84%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.